Institutional investors purchased a net $137.7 thousand shares of PDLI during the quarter ended December 2014 and now own 96.28% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST TRUST ADVISORS LP Bought 7.6 Million shares of PDL BioPharma Inc
LOMBARDIA CAPITAL PARTNERS LLC Bought 1.4 Million shares of PDL BioPharma Inc
BANK OF AMERICA, NA (PRIVATE BAN... Bought 1.1 Million shares of PDL BioPharma Inc